Oscar Health, Inc. Class A Common Stock (OSCR)
17.68
-0.25 (-1.42%)
NYSE · Last Trade: Sep 17th, 12:11 PM EDT
Check out the companies making headlines yesterday:
Via StockStory · September 17, 2025
The first rate cuts of the year are here.
Via The Motley Fool · September 17, 2025
Shares of health insurance company Oscar Health (NYSE:OSCR) fell 4.7% in the morning session after the company announced it is offering $355 million in convertible senior subordinated notes.
Via StockStory · September 16, 2025
Oscar Health's $355 million debt offering aims to fuel growth through AI initiatives, cost savings, and expanded healthcare benefits by 2030.
Via Benzinga · September 16, 2025
Oscar Health Inc (NYSE:OSCR) shares are trading lower Tuesday after the company announced an upsized offering of convertible senior notes.
Via Benzinga · September 16, 2025
Via Benzinga · September 16, 2025
U.S. stock futures advanced on Tuesday following Monday's positive moves. Futures of major benchmark indices were higher.
Via Benzinga · September 16, 2025
Oscar Health shares dropped 3.63% in after-hours trading, following the announcement of a $350 million convertible notes offering to fund strategic initiatives and reduce costs.
Via Benzinga · September 16, 2025
Oscar Health’s $350 million convertible notes due 2030 will help fund AI-driven expansion, member experience improvements, and could extend enhanced premium tax credits, while also replacing its revolving credit facility.
Via Stocktwits · September 15, 2025
OSCR stock is up 27% over the past couple of weeks.
Via The Motley Fool · September 12, 2025
Over the past six months, Oscar Health has been a great trade, beating the S&P 500 by 14.9%. Its stock price has climbed to $19.39, representing a healthy 32.4% increase. This performance may have investors wondering how to approach the situation.
Via StockStory · September 11, 2025
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.
Via StockStory · September 10, 2025
Investors are circling healthcare stocks because of the cheap valuations.
Via The Motley Fool · September 10, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Oscar Health (NYSE:OSCR) and the best and worst performers in the health insurance providers industry.
Via StockStory · September 8, 2025
The three stocks draw a surge in retail message volume between 700% and 1,000%.
Via Stocktwits · September 8, 2025
Via Benzinga · September 5, 2025
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Via StockStory · September 5, 2025
Oscar Health shares are extending gains on Thursday. The stock surged Wednesday after the company reaffirmed its fiscal year 2025 sales guidance.
Via Benzinga · September 4, 2025
Shares of Oscar Health are trading higher Wednesday afternoon. The company reaffirms its fiscal year 2025 sales guidance.
Via Benzinga · September 3, 2025
Via Benzinga · September 3, 2025
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Via StockStory · September 1, 2025
A number of stocks fell in the afternoon session after markets pulled back with the decline concentrated in the tech space as investors engaged in profit-taking following a robust week that saw the S&P 500 hit a new record.
Via StockStory · August 29, 2025
Great things are happening to the stocks in this article.
They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
Via StockStory · August 29, 2025
Hims & Hers, which boasts a $9.7 billion market cap, is up 170% over the past year, though it's pulled back nearly 25% this past month.
Via Benzinga · August 25, 2025
History never repeats itself, but it often rhymes.
Via The Motley Fool · August 25, 2025